The IFIMT1 assay was designed but not pursued, as sequencing data (performed as described for the TNF gene [39]) confirmed a trend for overall lower methylation in RA patients, but with very high heterogeneity. The gene discussed is TNF; the disease is rheumatoid arthritis.